Gliclazide
Showing 1 - 25 of 85
MODY1, MODY3 Trial in Oxford (Omission of gliclazide)
Completed
- MODY1
- MODY3
- Omission of gliclazide
-
Oxford, Oxfordshire, United KingdomClinical Research Unit, OCDEM, Churchill Hospital
Aug 16, 2022
Diabetes, Type 2 Trial in Sarajevo (Omeprazole, Placebo oral tablet, Gliclazide)
Completed
- Diabetes Mellitus, Type 2
- Omeprazole
- +2 more
-
Sarajevo, Bosnia and HerzegovinaGeneral Hospital Prim. Dr. Abdulah Nakas
Jul 19, 2021
Type2 Diabetes Trial in Amsterdam (EMPA/LINA 10/5 mg QD (n=22), LINA/EMPA 5/10 mg QD (N=22), Gliclazide 30 mg QD/BID (N=22))
Active, not recruiting
- Type2 Diabetes
- EMPA/LINA 10/5 mg QD (n=22)
- +2 more
-
Amsterdam, Noord-Holland, NetherlandsVU University Medical Center
Jan 13, 2022
Type 2 Diabetes, Mild Cognitive Impairment Trial in Nanjing (Henagliflozin, Gliclazide)
Recruiting
- Type 2 Diabetes Mellitus
- Mild Cognitive Impairment
- Henagliflozin
- Gliclazide
-
Nanjing, Jiangsu, ChinaDivision of Endocrinology, the Affiliated Drum Tower Hospital of
Oct 10, 2023
Diabetes Type 2 Trial in Doha (Metformin, Gliclazide, Sitagliptin)
Active, not recruiting
- Diabetes Mellitus Type 2
- Metformin
- +6 more
-
Doha, QatarHamad Medical Corporation
Apr 27, 2022
Type 2 Diabetes Trial in Dundee (Sulfonylurea, DPP4 Inhibitor)
Completed
- Type 2 Diabetes
- Sulfonylurea
- DPP4 Inhibitor
-
Dundee, United KingdomNinewells Hospital and Medical School
Mar 3, 2021
Tolerability of Gliclazide MR 60mg in Diabetic Patients Fasting
Completed
- Type 2 Diabetes
-
Suresnes, FranceServier Affaires Medicales
Jun 3, 2020
Diabetes, Type 2, Diabetic Nephropathies Trial in Amsterdam (Dapagliflozin 10mg QD, Gliclazide 30mg QD)
Completed
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Dapagliflozin 10mg QD
- Gliclazide 30mg QD
-
Amsterdam, Noord-Holland, NetherlandsVU University Medical Center
Jul 6, 2020
Diabetes, Type 2 Trial in Brampton, Etobicoke, Toronto (Basal insulin glargine and lixisenatide, Basal insulin Basaglar/Lantus +
Completed
- Diabetes Mellitus, Type 2
- Basal insulin glargine and lixisenatide
- +2 more
-
Brampton, Ontario, Canada
- +2 more
Feb 24, 2021
Psoriasis, Type 2 Diabetes Trial in Dublin 24, Dublin 4 (Sitagliptin, Gliclazide, Sitagliptin matched )
Completed
- Psoriasis
- Type 2 Diabetes Mellitus
- Sitagliptin
- +3 more
-
Dublin 24, Ireland
- +1 more
May 13, 2020
Type 2 Diabetes Trial in China (Gliclazide MR and Insulin Glargine Injection, Biosynthetic Human Insulin Injection)
Completed
- Type 2 Diabetes
- Gliclazide MR and Insulin Glargine Injection
- Biosynthetic Human Insulin Injection
-
Beijing, Beijing, China
- +7 more
Mar 29, 2020
Diabetes, Type 2 Trial in Curitiba (Dapagliflozin, Gliclazide MR)
Completed
- Diabetes Mellitus, Type 2
- Dapagliflozin
- Gliclazide MR
-
Curitiba, Parana, BrazilCentro de Diabetes Curitiba
Mar 1, 2020
Type 2 Diabetes Trial in Dundee (Gliclazide)
Completed
- Type 2 Diabetes Mellitus
- Gliclazide
-
Dundee, United KingdomNinewells Hospital and Medical School
Feb 20, 2020
Healthy Trial in Darmstadt (Metformin/Gliclazide Fixed Combination, Metformin, Gliclazide)
Completed
- Healthy
- Metformin/Gliclazide Fixed Combination
- +2 more
-
Darmstadt, GermanyPlease Contact the Merck KGaA Communication Center
Apr 26, 2019
Healthy Trial in Mexico City (Metformin/Gliclazide Fixed Combination)
Completed
- Healthy
- Metformin/Gliclazide Fixed Combination
-
Mexico City, MexicoCECYPE
Apr 18, 2019
Diabetes, Type 2 Trial in Leicester, Birmingham (Canagliflozin, Repaglinide, Pioglitazone)
Completed
- Diabetes Mellitus, Type 2
- Canagliflozin
- +4 more
-
Leicester, Leicestershire, United Kingdom
- +1 more
Jan 29, 2020
Endovascular Thrombectomy Trials Into Real-world Practice in
Recruiting
- Ischemic Stroke
- +5 more
- Thrombus analyses
- Imaging assessment
-
Linyi, Shandong, China
- +2 more
Nov 23, 2022
Diabetes Trial in Seongnam (Dapagliflozin, Gliclazide)
Completed
- Diabetes
- Dapagliflozin
- Gliclazide
-
Seongnam, Gyeonggi, Korea, Republic ofSeoul National University Bundang Hospital
Sep 9, 2018
Type 2 Diabetes Trial in Japan (ipragliflozin, Placebo, Sulfonylurea)
Completed
- Type 2 Diabetes Mellitus
- ipragliflozin
- +2 more
-
Chubu, Japan
- +6 more
Apr 29, 2019
T2DM (Type 2 Diabetes), Diet, Healthy, Renal Function Disorder Trial in Milano (Sulfa-zero: possible benefits of the treatment
Recruiting
- T2DM (Type 2 Diabetes Mellitus)
- +3 more
- Sulfa-zero: possible benefits of the treatment of new generation hypoglycaemic drugs compared to sulphonylureas
-
Milano, ItalyASST FBF-Sacco P.O. Sacco/Fatebenefratelli e Oftalmico
Sep 27, 2021
Resistance Training, Sport Performance, Muscle Recovery Trial in Porto Alegre (Resistance Training)
Unknown status
- Resistance Training
- +4 more
- Resistance Training
-
Porto Alegre, Rio Grande Do Sul, BrazilFundação Universitária de Cardiologia/ Instituto de Cardiologia
Jun 20, 2020
Type 2 Diabetes Trial in Seongnam (Ipragliflozin, Sitagliptin)
Recruiting
- Type 2 Diabetes Mellitus
-
Seongnam, Gyeonggi, Korea, Republic ofSeoul National University Bundang Hospital
Mar 29, 2021